M.D. Rackham

866 total citations
7 papers, 517 citations indexed

About

M.D. Rackham is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Molecular Biology. According to data from OpenAlex, M.D. Rackham has authored 7 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in M.D. Rackham's work include Malaria Research and Control (4 papers), Trypanosoma species research and implications (4 papers) and Research on Leishmaniasis Studies (3 papers). M.D. Rackham is often cited by papers focused on Malaria Research and Control (4 papers), Trypanosoma species research and implications (4 papers) and Research on Leishmaniasis Studies (3 papers). M.D. Rackham collaborates with scholars based in United Kingdom, United States and Tanzania. M.D. Rackham's co-authors include Edward W. Tate, Anthony J. Wilkinson, Robin J. Leatherbarrow, J.A. Brannigan, Megan H. Wright, Anthony A. Holder, John D. Harling, K. Rangachari, David K. Moss and Cyrille S. Kounde and has published in prestigious journals such as Chemical Communications, Nature Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

M.D. Rackham

7 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.D. Rackham United Kingdom 7 320 168 112 92 85 7 517
Stefan O. Ochiana United States 11 471 1.5× 60 0.4× 104 0.9× 49 0.5× 80 0.9× 14 590
Euna Yoo United States 16 381 1.2× 126 0.8× 106 0.9× 122 1.3× 290 3.4× 30 892
Fred E. Cohen United States 10 342 1.1× 85 0.5× 75 0.7× 49 0.5× 142 1.7× 11 520
Mark E. Zupec United States 15 326 1.0× 43 0.3× 59 0.5× 91 1.0× 115 1.4× 18 546
Joma Joy Singapore 12 289 0.9× 197 1.2× 45 0.4× 48 0.5× 98 1.2× 26 540
Chiung-Kuang Chen United States 7 266 0.8× 138 0.8× 196 1.8× 116 1.3× 148 1.7× 7 538
Eleanor F. Howland United States 5 323 1.0× 57 0.3× 67 0.6× 93 1.0× 74 0.9× 6 471
Fang Yuan China 10 127 0.4× 129 0.8× 35 0.3× 88 1.0× 120 1.4× 21 443
Corey L. Strickland United States 10 434 1.4× 72 0.4× 65 0.6× 156 1.7× 193 2.3× 22 609
Jiasheng Diao United States 5 488 1.5× 71 0.4× 57 0.5× 49 0.5× 51 0.6× 9 774

Countries citing papers authored by M.D. Rackham

Since Specialization
Citations

This map shows the geographic impact of M.D. Rackham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Rackham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Rackham more than expected).

Fields of papers citing papers by M.D. Rackham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.D. Rackham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Rackham. The network helps show where M.D. Rackham may publish in the future.

Co-authorship network of co-authors of M.D. Rackham

This figure shows the co-authorship network connecting the top 25 collaborators of M.D. Rackham. A scholar is included among the top collaborators of M.D. Rackham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.D. Rackham. M.D. Rackham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Miah, Afjal H., Ian E. Smith, M.D. Rackham, et al.. (2021). Optimization of a Series of RIPK2 PROTACs. Journal of Medicinal Chemistry. 64(17). 12978–13003. 49 indexed citations
2.
Kounde, Cyrille S., Maria M. Shchepinova, Marcel Muelbaier, et al.. (2020). A caged E3 ligase ligand for PROTAC-mediated protein degradation with light. Chemical Communications. 56(41). 5532–5535. 107 indexed citations
3.
Rackham, M.D., Zhiyong Yu, J.A. Brannigan, et al.. (2015). Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase. MedChemComm. 6(10). 1761–1766. 25 indexed citations
4.
Rackham, M.D., J.A. Brannigan, K. Rangachari, et al.. (2014). Design and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N-Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP). Journal of Medicinal Chemistry. 57(6). 2773–2788. 59 indexed citations
5.
Tate, Edward W., Andrew Bell, M.D. Rackham, & Megan H. Wright. (2013). N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis. Parasitology. 141(1). 37–49. 56 indexed citations
6.
Wright, Megan H., Barbara Clough, M.D. Rackham, et al.. (2013). Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach. Nature Chemistry. 6(2). 112–121. 166 indexed citations
7.
Rackham, M.D., J.A. Brannigan, David K. Moss, et al.. (2012). Discovery of Novel and Ligand-Efficient Inhibitors of Plasmodium falciparum and Plasmodium vivaxN-Myristoyltransferase. Journal of Medicinal Chemistry. 56(1). 371–375. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026